Functional disorders of the brain induced by synthesis of nucleotides containing 3-acetylpyridine.
D000227:Adenine Nucleotides / Q000096:biosynthesis*; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D001927:Brain Diseases / Q000139:chemically induced*; D002540:Cerebral Cortex / Q000473:pathology; D005493:Folic Acid Antagonists; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D006624:Hippocampus / Q000201:enzymology; D007700:Kinetics; D008291:Malate Dehydrogenase / Q000378:metabolism; D008854:Microscopy, Electron; D009069:Movement Disorders / Q000139:chemically induced; D009699:N-Glycosyl Hydrolases / Q000378:metabolism; D009243:NAD / Q000378:metabolism; D009249:NADP / Q000378:metabolism; D009457:Neuroglia / Q000473:pathology; D009536:Niacinamide / Q000037:antagonists & inhibitors; D010734:Phosphogluconate Dehydrogenase / Q000378:metabolism; D011725:Pyridines; D012316:RNA Nucleotidyltransferases / Q000037:antagonists & inhibitors; D051381:Rats
D000227:Adenine Nucleotides; D005493:Folic Acid Antagonists; D011725:Pyridines; D009243:NAD; D009536:Niacinamide; D009249:NADP; D008291:Malate Dehydrogenase; D010734:Phosphogluconate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D012316:RNA Nucleotidyltransferases; D009699:N-Glycosyl Hydrolases